The leading open access journal in the field of neurosciences, Molecular Neurodegeneration encompasses all aspects of neurodegeneration research at the molecular and cellular levels.
- Guojun Bu, Mayo Clinic, USA
- Huaxi Xu, Sanford Burnham Prebys Medical Discovery Institute, USA
News from Alzforum
21 January 2019
19 January 2019
18 January 2019
Molecular Neurodegeneration is the official journal of the BrightFocus Foundation.
2017 Journal Metrics
45.8 days to first decision for reviewed manuscripts only
36.8 days to first decision for all manuscripts
136.3 days from submission to acceptance
13.0 days from acceptance to publication
527 Altmetric mentions